Synthetic Biology Group member, Cesar de la Fuente named to MIT Technology Review’s Innovators under 35

by RLE at MIT | Jun 25, 2019 | News Links

Digitizing evolution to make better antibiotics «more» Related Links: 35 Innovators Under 35, Pioneers: In breaking with the old ways, they create better AI, antibiotics, and even architecture (MIT Technology Review) Un científico gallego, elegido por el MIT...

Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates

by RLE at MIT | Dec 7, 2018 | RLE Recent Papers

Marcelo D. T. Torres, Cibele N. Pedron, Yasutomi Higashikuni, Robin M. Kramer, Marlon H. Cardoso, Karen G. N. Oshiro, Octávio L. Franco, Pedro I. Silva Junior, Fernanda D. Silva, Vani X. Oliveira Junior, Timothy K....

MIT engineers repurpose wasp venom as an antibiotic drug

by RLE at MIT | Dec 7, 2018 | News Links

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells «more» Related Links: MIT engineers repurpose wasp venom as an antibiotic drug (MIT News) Synthetic Biology Group Professor...

Biological engineers discover new antibiotic candidates

by RLE at MIT | Aug 20, 2018 | News Links

Screen of human proteins reveals some with antimicrobial power. «more» Related Links: Biological engineers discover new antibiotic candidates (MIT News) Professor Timothy Lu Synthetic...

Artificial antimicrobial peptides could help overcome drug-resistant bacteria

by RLE at MIT | Apr 17, 2018 | News Links

With aid of computer algorithm, researchers develop peptides more powerful than those found in nature. «more» Related Links: Artificial antimicrobial peptides could help overcome drug-resistant bacteria (MIT News) Synthetic Biology Group Professor...